Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ROIV | AMGN | VRTX | BMY | GILD |
| Company | Roivant Sciences Ltd | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 11.18 | 279.38 | 465.19 | 56.18 | 88.39 |
| High | 11.23 | 281.36 | 468.88 | 56.84 | 89.04 |
| Low | 11.05 | 276.56 | 458.05 | 55.84 | 87.63 |
| Last | 11.16 | 278.76 | 467.01 | 56.80 | 88.46 |
| Change | -0.04 | -4.85 | +1.31 | +0.58 | +0.06 |
| % Change | -0.36% | -1.71% | +0.28% | +1.03% | +0.07% |
| Volume | 4,197,900 | 3,175,800 | 1,129,300 | 10,705,100 | 9,099,700 |
| 20-Day Average Volume | 4,286,470 | 2,594,705 | 1,218,120 | 11,810,790 | 7,558,300 |
| Previous Close | 11.20 | 283.61 | 465.70 | 56.22 | 88.40 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.67 | 312.04 | 482.60 | 55.14 | 90.79 |
| 20-Day Raw Stochastic | 10.70% | 4.26% | 14.49% | 53.83% | 21.50% |
| 20-Day Relative Strength | 41.74% | 26.82% | 45.23% | 57.91% | 50.61% |
| Weighted Alpha | +15.47 | -3.46 | +24.18 | +21.82 | +23.55 |
| Today's Opinion | 8% Sell | 40% Sell | 32% Buy | 100% Buy | 80% Buy |
| Previous Opinion | 16% Buy | 40% Sell | 16% Buy | 100% Buy | 80% Buy |
| Last Month's Opinion | 80% Buy | 24% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.50% since 11/11/24 | -13.38% since 11/11/24 | -6.92% since 11/11/24 | -5.05% since 11/11/24 | -8.83% since 11/11/24 |
| Low | 11.05 on 11/18/24 | 276.56 on 11/18/24 | 458.05 on 11/18/24 | 55.82 on 11/15/24 | 87.63 on 11/18/24 |
| High | 12.05 on 11/13/24 | 321.22 on 11/12/24 | 508.04 on 11/12/24 | 60.62 on 11/12/24 | 96.84 on 11/12/24 |
| 1-Month | |||||
| %Chg | -6.38% since 10/18/24 | -13.34% since 10/18/24 | -3.31% since 10/18/24 | +6.73% since 10/18/24 | +2.01% since 10/18/24 |
| Low | 11.05 on 11/18/24 | 276.56 on 11/18/24 | 458.05 on 11/18/24 | 51.81 on 10/28/24 | 85.60 on 10/22/24 |
| High | 12.12 on 11/11/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -0.27% since 08/16/24 | -13.28% since 08/16/24 | -2.17% since 08/16/24 | +15.07% since 08/16/24 | +19.90% since 08/16/24 |
| Low | 11.05 on 11/18/24 | 276.56 on 11/18/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 73.27 on 08/19/24 |
| High | 13.06 on 09/09/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -0.62% since 05/17/24 | -10.79% since 05/17/24 | +4.90% since 05/17/24 | +29.00% since 05/17/24 | +30.63% since 05/17/24 |
| Low | 10.00 on 08/05/24 | 276.56 on 11/18/24 | 435.57 on 05/30/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 13.06 on 09/09/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,282,646 | 152,449,728 | 119,931,248 | 114,024,112 | 110,169,920 |
| Shares Outstanding, K | 739,522 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 124,800,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | 4,348,930,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 55,130,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | 95,300,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 1.24 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.29 on 11/12/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/12/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.40 | 0.00 | 50.00 | 20.79 |